Clinical Trial Update: Biologic Basis Of Increased Susceptibility Of Smokers To Pulmonary Infection With Mycobacterium Tuberculosis

View source ↗

Summary

A clinical trial investigating the biologic basis for increased susceptibility of smokers to pulmonary tuberculosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Tuberculosis

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Tuberculosis, Chronic Obstructive Pulmonary Disease | Status: WITHDRAWN